Examining the utility of using genotype and functional biology in a clinical pharmacology trial: Pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder

David P. Graham; David A. Nielsen; Thomas R. Kosten; Lori L. Davis; Mark B. Hamner; Iouri Makotkine; Rachel Yehuda

doi:10.1097/YPG.0000000000000039

Examining the utility of using genotype and functional biology in a clinical pharmacology trial: Pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder

David P. Graham, David A. Nielsen, Thomas R. Kosten, Lori L. Davis, Mark B. Hamner, Iouri Makotkine, Rachel Yehuda

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	181-182
Number of pages	2
Journal	Psychiatric Genetics
Volume	24
Issue number	4
DOIs	https://doi.org/10.1097/YPG.0000000000000039
State	Published - Aug 2014

Access to Document

10.1097/YPG.0000000000000039

Cite this

Graham, D. P., Nielsen, D. A., Kosten, T. R., Davis, L. L., Hamner, M. B., Makotkine, I., & Yehuda, R. (2014). Examining the utility of using genotype and functional biology in a clinical pharmacology trial: Pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder. Psychiatric Genetics, 24(4), 181-182. https://doi.org/10.1097/YPG.0000000000000039

@article{10ca43c38d8e4afe9d7c3f0f516e5780,

title = "Examining the utility of using genotype and functional biology in a clinical pharmacology trial: Pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder",

author = "Graham, {David P.} and Nielsen, {David A.} and Kosten, {Thomas R.} and Davis, {Lori L.} and Hamner, {Mark B.} and Iouri Makotkine and Rachel Yehuda",

year = "2014",

month = aug,

doi = "10.1097/YPG.0000000000000039",

language = "English",

volume = "24",

pages = "181--182",

journal = "Psychiatric Genetics",

issn = "0955-8829",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "4",

}

Graham, DP, Nielsen, DA, Kosten, TR, Davis, LL, Hamner, MB, Makotkine, I & Yehuda, R 2014, 'Examining the utility of using genotype and functional biology in a clinical pharmacology trial: Pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder', Psychiatric Genetics, vol. 24, no. 4, pp. 181-182. https://doi.org/10.1097/YPG.0000000000000039

Examining the utility of using genotype and functional biology in a clinical pharmacology trial: Pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder. / Graham, David P.; Nielsen, David A.; Kosten, Thomas R. et al.
In: Psychiatric Genetics, Vol. 24, No. 4, 08.2014, p. 181-182.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Examining the utility of using genotype and functional biology in a clinical pharmacology trial

T2 - Pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder

AU - Graham, David P.

AU - Nielsen, David A.

AU - Kosten, Thomas R.

AU - Davis, Lori L.

AU - Hamner, Mark B.

AU - Makotkine, Iouri

AU - Yehuda, Rachel

PY - 2014/8

Y1 - 2014/8

UR - http://www.scopus.com/inward/record.url?scp=84903758030&partnerID=8YFLogxK

U2 - 10.1097/YPG.0000000000000039

DO - 10.1097/YPG.0000000000000039

M3 - Letter

C2 - 24983834

AN - SCOPUS:84903758030

SN - 0955-8829

VL - 24

SP - 181

EP - 182

JO - Psychiatric Genetics

JF - Psychiatric Genetics

IS - 4

ER -